Fungal Infection

A 5-year study of bimekizumab in ankylosing spondylitis encountered no new safety signals, with efficacy sustained even in a conservative analysis with non-responder imputation, according to data published in RMD Open.

Candida auris remained a serious public health threat in the United States, and a cat-transmitted fungal infection made its way to the U.S. for the first time.

Almirall has completed the decentralized regulatory procedure in Europe for efinaconazole for the treatment of onychomycosis, the company announced in a press release.

Invasive aspergillosis occurs in around 3% to 5% of children with acute leukemia, according to findings published in Journal of the Pediatric Infectious Diseases Society.

Healio has compiled June’s most-read news in dermatology.

Standard infection prevention and control procedures prevented the spread of Candida auris at a Tennessee dialysis facility despite two patients there being colonized for up to 4 months during treatment, researchers reported.

In January, the CDC warned physicians to be cautious when prescribing topical antifungals in light of the recent detection of antimicrobial-resistant superficial fungal infections in the United States.

The CDC is urging physicians to confirm a fungal diagnosis before prescribing topical antifungals in order to preserve their efficacy, as antimicrobial-resistant superficial fungal infections become more frequent.

Contamination of the health care environments near patients who are colonized with Candida auris often occurs within 4 hours, researchers found.

CDC advisors recommended that older adults talk to their doctors about getting vaccinated against respiratory syncytial virus using one of two recently approved shots.